82 related articles for article (PubMed ID: 3202879)
1. Characterization of activin A binding sites on the human leukemia cell line K562.
Campen CA; Vale W
Biochem Biophys Res Commun; 1988 Dec; 157(2):844-9. PubMed ID: 3202879
[TBL] [Abstract][Full Text] [Related]
2. Identification of the two types of specific receptor for activin/EDF expressed on Friend leukemia and embryonal carcinoma cells.
Kondo S; Hashimoto M; Etoh Y; Murata M; Shibai H; Muramatsu M
Biochem Biophys Res Commun; 1989 Jun; 161(3):1267-72. PubMed ID: 2545199
[TBL] [Abstract][Full Text] [Related]
3. Perifusion of rat pituitary cells with gonadotropin-releasing hormone, activin, and inhibin reveals distinct effects on gonadotropin gene expression and secretion.
Weiss J; Crowley WF; Halvorson LM; Jameson JL
Endocrinology; 1993 Jun; 132(6):2307-11. PubMed ID: 8504735
[TBL] [Abstract][Full Text] [Related]
4. Activin-A binding and biochemical effects in osteoblast-enriched cultures from fetal-rat parietal bone.
Centrella M; McCarthy TL; Canalis E
Mol Cell Biol; 1991 Jan; 11(1):250-8. PubMed ID: 1846021
[TBL] [Abstract][Full Text] [Related]
5. Activin A-induced differentiation in K562 cells is associated with a transient hypophosphorylation of RB protein and the concomitant block of cell cycle at G1 phase.
Sehy DW; Shao LE; Yu AL; Tsai WM; Yu J
J Cell Biochem; 1992 Nov; 50(3):255-65. PubMed ID: 1361489
[TBL] [Abstract][Full Text] [Related]
6. Functional regulation of osteoblastic cells by the interaction of activin-A with follistatin.
Hashimoto M; Shoda A; Inoue S; Yamada R; Kondo T; Sakurai T; Ueno N; Muramatsu M
J Biol Chem; 1992 Mar; 267(7):4999-5004. PubMed ID: 1537876
[TBL] [Abstract][Full Text] [Related]
7. Characterization of cellular receptors for erythroid differentiation factor on murine erythroleukemia cells.
Hino M; Tojo A; Miyazono K; Miura Y; Chiba S; Eto Y; Shibai H; Takaku F
J Biol Chem; 1989 Jun; 264(17):10309-14. PubMed ID: 2542329
[TBL] [Abstract][Full Text] [Related]
8. Rodent adrenocortical cells display high affinity binding sites and proteins for inhibin A, and express components required for autocrine signalling by activins and bone morphogenetic proteins.
Farnworth PG; Wang Y; Leembruggen P; Ooi GT; Harrison C; Robertson DM; Findlay JK
J Endocrinol; 2006 Mar; 188(3):451-65. PubMed ID: 16522726
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the activin receptor in cultured rat hepatocytes.
Zhang YQ; Kanzaki M; Mashima H; Mine T; Kojima I
Hepatology; 1996 Aug; 24(2):446-50. PubMed ID: 8690418
[TBL] [Abstract][Full Text] [Related]
10. Identification and characterization of binding proteins for inhibin and activin in human serum and follicular fluids.
Krummen LA; Woodruff TK; DeGuzman G; Cox ET; Baly DL; Mann E; Garg S; Wong WL; Cossum P; Mather JP
Endocrinology; 1993 Jan; 132(1):431-43. PubMed ID: 7678220
[TBL] [Abstract][Full Text] [Related]
11. Molecular cloning and binding properties of the human type II activin receptor.
Donaldson CJ; Mathews LS; Vale WW
Biochem Biophys Res Commun; 1992 Apr; 184(1):310-6. PubMed ID: 1314589
[TBL] [Abstract][Full Text] [Related]
12. Characterization of unique binding kinetics of follistatin and activin or inhibin in serum.
Schneyer AL; Rzucidlo DA; Sluss PM; Crowley WF
Endocrinology; 1994 Aug; 135(2):667-74. PubMed ID: 8033815
[TBL] [Abstract][Full Text] [Related]
13. Transforming growth factor-beta modulates inhibin A bioactivity in the LbetaT2 gonadotrope cell line by competing for binding to betaglycan.
Ethier JF; Farnworth PG; Findlay JK; Ooi GT
Mol Endocrinol; 2002 Dec; 16(12):2754-63. PubMed ID: 12456797
[TBL] [Abstract][Full Text] [Related]
14. Activin and inhibin binding to the soluble extracellular domain of activin receptor II.
Donaldson CJ; Vaughan JM; Corrigan AZ; Fischer WH; Vale WW
Endocrinology; 1999 Apr; 140(4):1760-6. PubMed ID: 10098513
[TBL] [Abstract][Full Text] [Related]
15. Localization of inhibin and activin binding sites in the testis during development by in situ ligand binding.
Krummen LA; Moore A; Woodruff TK; Covello R; Taylor R; Working P; Mather JP
Biol Reprod; 1994 Apr; 50(4):734-44. PubMed ID: 8199254
[TBL] [Abstract][Full Text] [Related]
16. Activin B: precursor sequences, genomic structure and in vitro activities.
Mason AJ; Berkemeier LM; Schmelzer CH; Schwall RH
Mol Endocrinol; 1989 Sep; 3(9):1352-8. PubMed ID: 2575216
[TBL] [Abstract][Full Text] [Related]
17. In vitro ligand binding of 125I-recombinant human activin A to the female rat brain.
Jakeman L; Mather J; Woodruff T
Endocrinology; 1992 Dec; 131(6):3117-9. PubMed ID: 1446646
[TBL] [Abstract][Full Text] [Related]
18. Response of human fetal pituitary cells to activin, inhibin, hypophysiotropic and neuroregulatory factors in vitro.
Blumenfeld Z
Early Pregnancy (Cherry Hill); 2001 Jan; 5(1):41-2. PubMed ID: 11753507
[TBL] [Abstract][Full Text] [Related]
19. Production of activin-binding protein by rat granulosa cells in vitro.
Saito S; Nakamura T; Titani K; Sugino H
Biochem Biophys Res Commun; 1991 Apr; 176(1):413-22. PubMed ID: 1902106
[TBL] [Abstract][Full Text] [Related]
20. Differential control of activin, inhibin and follistatin proteins in cultured rat granulosa cells.
Miyanaga K; Erickson GF; DePaolo LV; Ling N; Shimasaki S
Biochem Biophys Res Commun; 1993 Jul; 194(1):253-8. PubMed ID: 8333840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
